Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects

Fig. 4

Clinical effect of AMG 403 in patients with knee osteoarthritis. Mean change (+ standard error) from baseline values over time for each dose group were plotted for total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) (a) score and visual analog score (VAS) (b) for patient disease assessment. Arrows represent subcutaneous dose administrations (SC)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us